P. Calès

发表

A novel panel of blood markers to assess the degree of liver fibrosis

F. Oberti, P. Calès, S. Michalak, 2005, Hepatology.

Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers.

D Chappard, P. Bedossa, D. Chappard, 1998, Journal of hepatology.

The combination of a blood test and Fibroscan improves the non‐invasive diagnosis of liver fibrosis

V. de Lédinghen, F. Oberti, P. Calès, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Sources of variability in histological scoring of chronic viral hepatitis

Paul Calès, Pierre Bedossa, P. Bedossa, 2005, Hepatology.

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy

Julien Vergniol, Christophe Aubé, V. de Lédinghen, 2016, Hepatology.

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C

S. Bertrais, Y. Bacq, F. Oberti, 2014, Journal of Gastroenterology.

Liver fibrosis in patients with non-alcoholic fatty liver disease: diagnostic options in clinical practice.

C. Aubé, P. Calès, M. Rousselet, 2012, Expert opinion on medical diagnostics.

Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C

R. Luiz, P. Calès, V. Pannain, 2017, World journal of hepatology.

Non‐selective beta‐blockers increase overall and liver mortality in alcoholic cirrhosis with MELD ≥ 12 over 5 years of follow‐up

S. Bertrais, F. Oberti, P. Calès, 2020, Liver international (Print).

New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis

C. Aubé, F. Oberti, P. Calès, 2004, European journal of gastroenterology & hepatology.

Gastroesophageal endoscopic signs of cirrhosis : independent diagnostic accuracy, interassociation, and relationship to etiology and hepatic dysfunction

F. Oberti, P. Calès, C. Pilette, 1998 .

Renal macro- and microcirculation autoregulatory capacity during early sepsis and norepinephrine infusion in rats

P. Asfar, J. Hamel, A. Mercat, 2013, Critical Care.

Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol.

P. Calès, D. Lebrec, A. Braillon, 1985, Journal of hepatology.

IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells

P. Roingeard, C. Créminon, H. Fickenscher, 2014, Gut.

Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.

R. Boisgard, B. Tavitian, D. Samuel, 2007, Gastroenterology.

[Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha].

P. Duverger, F. Oberti, P. Calès, 1998, Gastroenterologie clinique et biologique.

Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.

D. Chappard, F. Oberti, P. Calès, 2002, Journal of hepatology.

Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine-pancreas gene as a liver tumor-specific promoter.

R. Boisgard, B. Tavitian, D. Samuel, 2008, Human gene therapy.

Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients

X. Causse, F. Bonnet, F. Laine, 2017, Hepatology.

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

Vincent Leroy, Paul Calès, S. Bertrais, 2011, The American Journal of Gastroenterology.

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

V. de Lédinghen, C. Aubé, F. Oberti, 2017, Alimentary pharmacology & therapeutics.

A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases

V. de Lédinghen, B. le Bail, P. Calès, 2017, Journal of clinical gastroenterology.

Can we precisely classify liver fibrosis without biopsy in hepatitis C

P. Calès, J. Boursier, 2012 .

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive

V. de Lédinghen, F. Oberti, P. Calès, 2012, Hepatology.

Response to Munteanu et al.

F. Oberti, P. Calès, J. Boursier, 2011, The American Journal of Gastroenterology.

FibroMeters: a family of blood tests for liver fibrosis.

G. Hunault, F. Oberti, P. Calès, 2008, Gastroenterologie clinique et biologique.

Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests.

V. de Lédinghen, Y. Bacq, F. Oberti, 2008, Gastroenterologie clinique et biologique.

1048 ACCURACY OF LIVER FIBROSIS CLASSIFICATIONS PROVIDED BY NON-INVASIVE TESTS

S. Bertrais, F. Oberti, P. Calès, 2010 .

Diagnosis and Measurement of Liver Fibrosis by MRI in Bile Duct Ligated Rats

C. Aubé, F. Oberti, P. Calès, 2007, Digestive Diseases and Sciences.

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, JHEP reports : innovation in hepatology.

Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy?

F. Oberti, P. Calès, B. Fabiani, 1997, Gastrointestinal endoscopy.

Optimization and robustness of blood tests for liver fibrosis and cirrhosis.

S. Bertrais, F. Oberti, P. Calès, 2010, Clinical biochemistry.

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.

F. Carrat, C. Michelet, D. Guyader, 2010, Journal of hepatology.

Liver haemangioma and pregnancy

Y. Itai, M. Malaguarnera, P. Calès, 1996, The Lancet.

Diagnostic non invasif de l'hypertension portale au cours de la cirrhose

F. Oberti, P. Calès, A. Konaté, 2005 .

Session 2 ‒ Diagnosis of Portal Hypertension: How and When

F. Nevens, M. Zoli, G. D’Amico, 2008 .

Large oesophageal varice screening by a sequential algorithm using a cirrhosis blood test and optionally capsule endoscopy

D. Valla, J. Galmiche, C. Bureau, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Vascular involvement of the liver in Turner's syndrome

D. Valla, C. Degott, D. Roulot, 2004, Hepatology.

Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C

V. de Lédinghen, Y. Bacq, G. Hunault, 2008, Liver international : official journal of the International Association for the Study of the Liver.

Comparison of screening strategies with two new tests to score and diagnose varices needing treatment.

V. de Lédinghen, C. Vitellius, P. Nahon, 2022, Clinics and research in hepatology and gastroenterology.

Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial.

D. Roulot, A. Tran, F. Degos, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Prothrombin index is an indirect marker of severe liver fibrosis

D. Chappard, F. Oberti, P. Calès, 2002, European journal of gastroenterology & hepatology.

Recombinant human α‐interferon in patients with chronic non‐A, non‐B hepatitis: A multicenter randomized controlled trial from France

P. Couzigou, P. Marcellin, C. Degott, 1991 .

Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.

V. de Lédinghen, G. Markakis, S. Mueller, 2020, Journal of hepatology.

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

P. Marcellin, D. Thabut, F. Carrat, 2019, BMC Infectious Diseases.

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.

V. de Lédinghen, P. Marcellin, D. Thabut, 2019, Gastroenterology.

[Study of antigen HBs and antivirus antibodies of hepatitis C during hepatopathies in Mali].

H. Traoré, P. Calès, B. Carbonnelle, 2004, Bulletin de la Societe de pathologie exotique.

Colonic investigations in the elderly: Colonoscopy or barium enema?

P. Calès, P. Burtin, B. Bour, 1995, Aging.

Current management of the complications of portal hypertension: variceal bleeding and ascites

F. Oberti, P. Calès, N. Dib, 2006, Canadian Medical Association Journal.

cirrhosis . propranolol in patients with haemodynamics and on response to on systemic and splanchnic Influence of the degree of liver failure

P. Calès, D. Lebrec, A. Braillon, 2006 .

Influence of the degree of liver failure

D. Valla, P. Calès, A. Braillon, 2006 .

Early administration of vapreotide for variceal bleeding in patients with cirrhosis.

D. Valla, F. Durand, F. Saliba, 2001, The New England journal of medicine.

Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis.

J. Vinel, J. Chayvialle, P. Calès, 1995, Gastroenterology.

Weakness of mucosal barrier in portal hypertensive gastropathy of alcoholic cirrhosis. Effects of propranolol and enprostil.

J. Frexinos, P. Calès, J. Payen, 1995, Journal of hepatology.

Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension.

S. Urien, J. Vinel, P. Calès, 1993, Journal of hepatology.

Propranolol does not alter cerebral blood flow and functions in cirrhotic patients without previous hepatic encephalopathy

J. Vinel, P. Calès, G. Géraud, 1989, Hepatology.

Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.

A. Ravaud, J. Vinel, P. Calès, 1989, British journal of clinical pharmacology.

Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis.

D. Valla, P. Calès, D. Lebrec, 1986, Gut.

Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.

G. Feldmann, J. Saumet, F. Oberti, 1997, Journal of hepatology.

Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.

F. Carrat, F. Lescure, G. Pialoux, 2010, The American journal of tropical medicine and hygiene.

Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography:

F. Oberti, P. Calès, I. Hubert-Fouchard, 2017 .

Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C‐infected haemophilia patients

J. Schapiro, Y. Maor, G. Kenet, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.

V. de Lédinghen, T. Asselah, D. Thabut, 2020, Journal of hepatology.

Radiation-induced cholangitis with hepatocellular carcinoma.

J. Tran van Nhieu, F. Caroli-Bosc, J. Nhieu, 2010, Gastroenterologie clinique et biologique.

The noninvasive diagnosis of esophageal varices and its application in clinical practice.

F. Oberti, P. Calès, E. Pateu, 2017, Clinics And Research in Hepatology and Gastroenterology.

A major new step in non‐invasive evaluation of portal hypertension: elastography

C. Bureau, P. Calès, V. Martino, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Failure to Control Bleeding and Failure to Control Rebleeding

A. Burroughs, D. Thabut, G. D’Amico, 2010 .

Vapreotide acetate for the treatment of esophageal variceal bleeding

P. Calès, 2008, Expert review of gastroenterology & hepatology.

Doppler ultrasonography devices, including elastography, allow for accurate diagnosis of severe liver fibrosis.

C. Aubé, F. Oberti, P. Calès, 2018, European journal of radiology.

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, Journal of Cannabis Research.

[Observer variability].

P. Calès, P. Burtin, 1998, Gastroenterologie clinique et biologique.

Hemodynamic evaluation of molsidomine: A vasodilator with antianginal properties in patients with alcoholic cirrhosis

J. Vinel, P. Calès, J. Combis, 1990, Hepatology.

New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.

V. de Lédinghen, B. le Bail, C. Bureau, 2019, Journal of hepatology.

Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non‐alcoholic fatty liver disease from tertiary care centres

P. Gourdy, C. Bureau, J. Selves, 2019, Alimentary pharmacology & therapeutics.

Obstructive sleep apnoea and non-alcoholic fatty liver disease: Which patients should be referred to hepatologists?

W. Trzepizur, P. Calès, J. Boursier, 2019, Clinics and research in hepatology and gastroenterology.

The effects of vasopressin and its analogues on the liver and its disorders in the critically ill

P. Asfar, P. Radermacher, F. Oberti, 2010, Current opinion in critical care.

Laser ablation of microdroplets for copper isotopic analysis via MC-ICP-MS. Analysis of serum microsamples for the diagnosis and follow-up treatment of Wilson's disease

F. V. Nakadi, P. Calès, B. Lelièvre, 2021 .

ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts

V. de Lédinghen, P. Marcellin, S. Chevret, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Radiofrequency thermal ablation of liver carcinoma. Prospective study of 82 lesions.

Patrick Pessaux, C. Aubé, F. Oberti, 2006, Gastroenterologie clinique et biologique.

Effects of Octreotide on Intestinal Transit and Bacterial Translocation in Conscious Rats with Portal Hypertension and Liver Fibrosis

F. Oberti, P. Calès, C. Lemarié, 2001, Digestive Diseases and Sciences.

Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis.

J. Vinel, P. Calès, J. Combis, 1989, Journal of hepatology.

Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis.

R. Moreau, D. Pateron, P. Sogni, 1999, Clinical science.

Alteration in response of the portal tributary vascular bed to the beta-agonist dobutamine in rats with extrahepatic portal hypertension.

P. Calès, D. Lebrec, A. Braillon, 1986, Journal of hepatology.

Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats.

P. Calès, D. Lebrec, A. Braillon, 1985, Journal of hepatology.

Atrial natriuretic peptide, plasma renin activity, plasma volume, systemic vascular resistance and cardiac output in patients with cirrhosis

P. Braquet, J. Vinel, P. Calès, 1989, Journal of gastroenterology and hepatology.

Simple blood fibrosis tests reduce unnecessary referrals for specialized evaluations of liver fibrosis in NAFLD and ALD patients.

G. Hunault, F. Oberti, P. Calès, 2020, Clinics and research in hepatology and gastroenterology.

Colonic arterial spider in cirrhosis.

P. Calès, J. Payen, J. Pascal, 1991, Gastrointestinal endoscopy.

[Association of hepatic adenomatosis and hepatoportal sclerosis in a woman with incontinentia pigmenti].

J. Belghiti, F. Oberti, P. Calès, 1997, Gastroenterologie clinique et biologique.

[FibroMeters: a family of blood tests for liver fibrosis with high diagnostic performance and applicability in clinical practice].

F. Oberti, P. Calès, Y. Gallois, 2009, Pathologie-biologie.

Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment.

V. de Lédinghen, P. Couzigou, P. Marcellin, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.

J. Saumet, F. Oberti, P. Calès, 1997, Journal of hepatology.

A novel spleen‐dedicated stiffness measurement by FibroScan® improves the screening of high‐risk oesophageal varices

N. Ganne-Carrié, G. Marasco, F. Ravaioli, 2020, Liver international : official journal of the International Association for the Study of the Liver.

How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests

G. Marasco, F. Ravaioli, D. Festi, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Screening of esophageal varices by esophageal capsule endoscopy: results of a French multicenter prospective study

P. Couzigou, D. Valla, J. Galmiche, 2015, Endoscopy.

[Interobserver and intercenter agreement of gastro-esophageal endoscopic signs in cirrhosis. Results of a prospective multicenter study].

L. Buscail, M. Dapoigny, P. Calès, 1989, Gastroenterologie clinique et biologique.

Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats*

R. Andriantsitohaina, P. Asfar, F. Meziani, 2009, Critical care medicine.

Reply to: "Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FMVCTE algorithm" and to "Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes".

V. de Lédinghen, P. Calès, V. Leroy, 2018, Journal of hepatology.

Screening of advanced liver fibrosis: one step at a time

P. Calès, V. Leroy, J. Boursier, 2017 .

Reply to: “Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FM VCTE algorithm”

P. Calès, V. Leroy, J. Boursier, 2017 .

Effect of Age, Tumor Risk, and Comorbidity in a U.S. Population–Based Cohort of Men With Prostate Cancer

V. de Lédinghen, P. Calès, J. Guéchot, 2013, Annals of Internal Medicine.

Late onset of Wilson's disease in a family with genetic haemochromatosis

P. Calès, M. Misrahi, N. Dib, 2006, European journal of gastroenterology & hepatology.

Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.

P. Calès, F. Lunel, F. Le Gal, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.

M. Ziol, V. de Lédinghen, P. Marcellin, 2017, Gastroenterology.

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

V. de Lédinghen, T. Asselah, D. Thabut, 2021, BMC Infectious Diseases.

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients

M. Ziol, V. de Lédinghen, P. Marcellin, 2018, American heart journal.

Effect of propranolol on hepatic blood flow in patients with cirrhosis

D. Valla, P. Calès, D. Lebrec, 1985, Clinical pharmacology and therapeutics.

[Immunochemical diagnosis of hepatic localizations in malignant lymphoid hematologic diseases. Study of 80 cases].

G. Delsol, J. Vinel, P. Calès, 1989, Gastroenterologie clinique et biologique.

Hepatitis C, alpha interferon, anxiety and depression disorders: A prospective study of 71 patients

B. Gohier, P. Calès, I. Fouchard, 2003, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

HÉMORRAGIES DIGESTIVES

P. Calès, E. Barrière, 2004 .

Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis.

J. Vinel, P. Calès, J. Voigt, 1988, Journal of hepatology.

Optimal use of propranolol in portal hypertension.

P. Calès, 2005, Gastroenterologie clinique et biologique.

Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.

F. Oberti, D. Bonnefont-Rousselot, P. Calès, 2006, World journal of gastroenterology.

Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension

F. Oberti, P. Calès, S. Michalak, 2008, Hepatology international.

[Interobserver concordance of echographic semiology in liver cirrhosis].

C. Aubé, P. Calès, A. Namour, 1995, Gastroenterologie clinique et biologique.

Gastroesophageal endoscopic features in cirrhosis: comparison of intracenter and intercenter observer variability.

P. Calès, J. Pascal, 1990, Gastroenterology.

Endoscopic ultrasonographic signs of portal hypertension in cirrhosis.

F. Oberti, P. Calès, P. Burtin, 1996, Gastrointestinal endoscopy.

[Evaluation of the blood flow of superior portacaval anastomoses by the measurement of azygos blood flow in patients with alcoholic cirrhosis].

P. Calès, D. Lebrec, A. Braillon, 1984, Gastroenterologie clinique et biologique.

Multicenter Randomized Controlled Trial of Terlipressin Versus Sclerotherapy in the Treatment of Acute Variceal Bleeding: The TEST Study

D. Pateron, J. Vinel, J. Bosch, 2000, Hepatology.

Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension.

D. Valla, D. Guyader, P. Blanc, 1999, European journal of gastroenterology & hepatology.

Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats*

P. Asfar, J. Saumet, F. Oberti, 2003, Critical care medicine.

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity

S. Bertrais, S. Castelain, B. Roquebert, 2016, Journal of gastroenterology and hepatology.

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)

P. Marcellin, F. Roudot-thoraval, F. Zoulim, 2016, Hepatology.

Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats.

F. Oberti, P. Calès, C. Pilette, 2000, Journal of hepatology.

Splenorenal shunt blood flow by transit‐time ultrasound as an index of collateral circulation in portal hypertensive rats

C. Aubé, F. Oberti, P. Calès, 1998, Hepatology.

Should measurements of hemodynamics in portal hypertension be dynamic?

P. Calès, 1998, Journal of hepatology.

Measurement of collateral circulation blood flow in anesthetized portal hypertensive rats.

C. Aubé, F. Oberti, P. Calès, 1998, Gastroenterologie clinique et biologique.

Performance of FibroScan® to detect large esophageal varices in chronic liver diseases is improved by a novel spleen-dedicated examination

N. Ganne-Carrié, H. Stefanescu, D. Festi, 2017 .

Non-invasive diagnosis of esophageal varices in chronic liver diseases.

P. Bedossa, C. Aubé, F. Oberti, 1999, Journal of hepatology.

Spontaneous regression of esophageal varices is a phenomenon that has spontaneously disappeared from our memory.

F. Oberti, P. Calès, P. Burtin, 1991, Journal of hepatology.

Portal hypertension 2

G. Minoli, P. Calès, W. Fleig, 1996 .

Interobserver agreement in endoscopic ultrasonography staging of esophageal and cardia cancer.

L. Palazzo, G. Roseau, B. Napoléon, 1996, Gastrointestinal endoscopy.

Interferon alpha therapy in haemophilic patients with chronic hepatitis C: a French multicentre pilot study of 58 patients

M. Bertrand, J. Goudemand, C. Trépo, 2001, European journal of gastroenterology & hepatology.

Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C

V. de Lédinghen, Y. Bacq, F. Oberti, 2009, European journal of gastroenterology & hepatology.

Comparison of blood tests for liver fibrosis specific or not to NAFLD.

F. Laine, Y. Deugnier, G. Hunault, 2009, Journal of hepatology.

Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data.

Y. Bacq, G. Hunault, P. Halfon, 2008, Clinical biochemistry.

Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats

P. Asfar, P. Radermacher, F. Meziani, 2010, Critical care.

COVID-19 infection in first trimester of pregnancy marked by a liver cytolysis in a woman previously treated by hydroxychloroquine for repeated implantation failure: a case report

P. Calès, V. Letouzey, P. Descamps, 2020, BMC Infectious Diseases.

Chronic vomiting in a case of citrullinaemia detected after treatment by total parenteral nutrition.

P. Calès, G. Bommelaer, A. Ribet, 1984, Gut.

Determination of reliability criteria for liver stiffness evaluation by transient elastography

V. de Lédinghen, S. Bertrais, F. Oberti, 2013, Hepatology.

Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3‐ and 6‐month periodicities

V. Vilgrain, S. Chevret, V. Bourcier, 2011, Hepatology.

[Hematologic manifestations related to hepatitis A virus. 3 cases].

N. Ifrah, M. Maiga, F. Oberti, 1997, Gastroenterologie clinique et biologique.

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Julien Vergniol, Paul Calès, V. de Lédinghen, 2016, Journal of hepatology.

Mediastinal posterior choriocarcinoma with hemorrhagic gastric metastasis: endosonographic features.

P. Calès, P. Burtin, J. Boyer, 1992, Gastrointestinal endoscopy.

Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.

F. Oberti, P. Calès, C. Pilette, 1998, Journal of hepatology.

[Anti-fibrotic effects of interferons. Mechanisms of action and therapeutic prospects].

P. Calès, C. Pilette, H. Rifflet, 1997, Gastroenterologie clinique et biologique.

Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats

F. Oberti, P. Calès, M. Rousselet, 1998, Hepatology.

Hemodynamic Effects of Acute and Chronic Administration of Vapreotide in Rats with Cirrhosis

F. Oberti, P. Calès, É. Vuillemin, 2004, Digestive Diseases and Sciences.

Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases.

P. Marcellin, D. Samuel, N. Ganne-Carrié, 2006, Journal of hepatology.

Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.

M. Loriot, P. Marcellin, F. Degos, 1995, Gut.

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Lawrence A. David, J. Rawls, G. Hunault, 2016, Hepatology.

Apoptosis and liver fibrosis: antifibrotic strategies.

P. Calès, 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Diagnostic accuracy of biochemical markers of fibrosis in black African patients with chronic hepatitis B

A. Mahassadi, F. Bathaix, P. Calès, 2010 .

Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats

Paul Calès, Daniel Chappard, D. Chappard, 2002, Hepatology.

Long-term administration of PGE1 increases liver fibrosis and collateral blood flow in bile-duct-ligated rats.

F. Oberti, P. Calès, Y. Gallois, 1999, Journal of hepatology.

New method of cardiac output measurement using ultrasound velocity dilution in rats.

J. Saumet, E. Roy, F. Oberti, 2001, Journal of applied physiology.

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

T. Asselah, P. Marcellin, D. Thabut, 2019, The Lancet.

Effects of long-term administration of interferon α in two models of liver fibrosis in rats

F. Oberti, P. Calès, Y. Gallois, 1998 .

Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats.

F. Oberti, P. Calès, Y. Gallois, 1998, Journal of hepatology.

The severity of NAFLD is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.

J. Rawls, G. Hunault, M. Barret, 2015 .

Treatment of liver fibrosis: clinical aspects.

F. Oberti, P. Calès, M. Rousselet, 2009, Gastroenterologie clinique et biologique.

304520_Journal May

B. Gohier, P. Calès, I. Fouchard, 2005 .

Assessment of renal hemodynamic toxicity of fluid challenge with 0.9% NaCl compared to balanced crystalloid (PlasmaLyte®) in a rat model with severe sepsis

P. Asfar, P. Radermacher, D. Henrion, 2017, Annals of Intensive Care.

Noninvasive diagnosis of hepatic fibrosis or cirrhosis.

P. Bedossa, C. Aubé, F. Oberti, 1997, Gastroenterology.

Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomy.

J. Vinel, P. Calès, B. Pradère, 1993, Gut.

Antral motility in patients with cirrhosis with or without gastric antral vascular ectasia.

P. Calès, J. Boyer, J. Charneau, 1995, Gut.

Fibrinogen angers with a new deletion (γ GVYYQ 346‐350) causes hypofibrinogenemia with hepatic storage

P. de Mazancourt, P. Calès, S. Michalak, 2007, Journal of thrombosis and haemostasis : JTH.

Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort.

V. de Lédinghen, T. Asselah, F. Carrat, 2020, Clinics and research in hepatology and gastroenterology.

[Gastric modifications in cirrhosis].

P. Calès, J. Payen, 1991, Gastroenterologie clinique et biologique.

Liver fibrosis staging by computed tomography: prospective randomized multicentric evaluation of image analyses.

C. Vitellius, C. Aubé, F. Oberti, 2021, Clinics and research in hepatology and gastroenterology.

Propranolol in the prevention of ascites

P. Calès, 1991, The Lancet.

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.

V. de Lédinghen, S. Imbeaud, J. Zucman‐Rossi, 2018, Gastroenterology.

Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study.

T. Asselah, D. Thabut, F. Carrat, 2021, Clinics and research in hepatology and gastroenterology.

Treatment of Chronic Hepatitis C With Amantadine

F. Oberti, P. Calès, F. Lunel, 1999, American Journal of Gastroenterology.

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.

T. Poynard, P. Calès, D. Lebrec, 1991, The New England journal of medicine.

Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction.

J. Fermanian, J. Vinel, P. Calès, 1990, Gastroenterology.

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

A. Ravaud, P. Gerin, J. Vinel, 1990, Gut.

[Recurrent stomal hemorrhage treated by transjugular intrahepatic portosystemic anastomosis and embolization of stomal varices].

C. Aubé, F. Oberti, P. Calès, 1998, Journal de radiologie.

[Stomal varices treated by glue embolization].

C. Aubé, F. Oberti, P. Calès, 2007, Gastroenterologie clinique et biologique.

A Novel FibroScan Examination Dedicated to Spleen Stiffness Measurement.

L. Sandrin, H. Stefanescu, D. Festi, 2018, Ultrasound in medicine & biology.

[Non-invasive diagnosis of portal hypertension in cirrhosis. Application to the primary prevention of varices].

F. Oberti, P. Calès, A. Konaté, 2005, Gastroenterologie clinique et biologique.

Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration.

J. Vinel, P. Calès, B. Pradère, 1992, Gastroenterology.

Gastric mucosal surface in cirrhosis evaluated by magnifying endoscopy and scanning electronic microscopy.

M. Baslé, F. Oberti, J. Arnaud, 2000, Endoscopy.

Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis.

P. Bedossa, C. Aubé, F. Oberti, 1999, Journal of hepatology.

[Budd-Chiari syndrome due to membranous obstruction of the inferior vena cava of congenital origin. Ten-year follow-up after radiologic treatment].

C. Aubé, F. Oberti, P. Calès, 1999, Gastroenterologie clinique et biologique.

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.

P. Calès, J. Pascal, 1987, The New England journal of medicine.

Interobserver agreement on endoscopic diagnosis of bleeding peptic ulcers.

F. Oberti, P. Calès, P. Burtin, 1997, Gastrointestinal endoscopy.

Infection et rupture de varice œsophagienne au cours de la cirrhose

P. Asfar, P. Calès, M. Joly-Guillou, 2007 .

Propranolol in the Primary Prevention of Upper Gastrointestinal Tract Haemorrhage in Patients with Cirrhosis of the Liver and Oesophageal Varices

P. Calès, J. Pascal, 2012, Drugs.

In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel.

O. Couturier, J. Benoit, A. Lamprecht, 2007, International journal of pharmaceutics.

Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities

P. Abraham, C. Aubé, W. Trzepizur, 2018, European Respiratory Journal.

Could splenectomy worsen autoimmune manifestations?

J. Vinel, P. Calès, J. Pascal, 1990, Journal of internal medicine.

A predictive score of inadequate bowel preparation based on a self-administered questionnaire: PREPA-CO.

S. Bertrais, A. Becq, C. Vitellius, 2021, Clinics and research in hepatology and gastroenterology.

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.

Albert Tran, Vincent Leroy, Dominique Larrey, 2018, Gastroenterology.

A not so solitary fibrous tumor of the liver.

C. Brochard, H. Fournier, C. Aubé, 2010, Gastroenterologie clinique et biologique.

Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C

S. Bertrais, F. Oberti, P. Calès, 2014, Hepatology.

Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis.

M. Ziol, V. de Lédinghen, J. Zucman‐Rossi, 2022, Journal of hepatology.

Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)

V. de Lédinghen, P. Marcellin, F. Roudot-thoraval, 2015, Gut.

A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy.

F. Aubin, F. Carbonnel, D. Wendling, 2020, Clinics and research in hepatology and gastroenterology.

Evaluation of Baveno recommendations for grading esophageal varices.

F. Oberti, P. Calès, J. Payen, 2003, Journal of hepatology.

FRI-010-Bezafibrate add-on therapy in high-risk primary biliary cholangitis is associated with an improvement of fibrometer and fibrometer-VCTE, two high-accuracy non-invasive fibrosis tests extensively validated in frequent chronic liver diseases

A. Rousseau, O. Chazouilleres, C. Corpechot, 2019, Journal of Hepatology.

How does endoscopic sclerotherapy alter splanchnic hemodynamics?

P. Calès, J. Gumucio, 1991, Hepatology.

[Occurrence of hepatic hemangiomas in pregnancy].

P. Calès, I. Fouchard, L. Rosenau, 1994, Gastroenterologie clinique et biologique.

[Progression of a hepatic hemangioma under progestins].

C. Aubé, P. Calès, B. Winkfield, 2001, Gastroentérologie Clinique et Biologique.

[Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results].

C. Aubé, F. Oberti, P. Calès, 2004, Journal de radiologie.

Prospective study on the application of the Baveno II Consensus Conference criteria in patients with cirrhosis and gastrointestinal bleeding.

J. Vinel, P. Calès, D. Lebrec, 2000, Journal of hepatology.

The Osteopontin Level in Liver, Adipose Tissue and Serum Is Correlated with Fibrosis in Patients with Alcoholic Liver Disease

Y. Le Marchand-Brustel, P. Gual, S. Patouraux, 2012, PloS one.

IL‐34 and macrophage colony‐stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells

P. Roingeard, P. Calès, L. Preisser, 2014, Hepatology.

Diagnosis of different liver fibrosis characteristics by blood tests in non‐alcoholic fatty liver disease

S. Bertrais, C. Cavaro-Ménard, F. Laine, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C

S. Bertrais, C. Brochard, F. Oberti, 2014, Alimentary pharmacology & therapeutics.

Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C

S. Bertrais, F. Oberti, P. Calès, 2011, BMC gastroenterology.

Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication

V. de Lédinghen, P. Marcellin, E. Letouzé, 2018, Hepatology.

Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury.

F. Goupil, W. Trzepizur, P. Calès, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[Nitric oxide and liver diseases: deleterious or hepatoprotective role].

P. Calès, C. Pilette, O. Douay, 1999, Gastroenterologie clinique et biologique.

[Favourable course of a pseudotumoral form of hepatic and splenic sarcoidosis under treatment with hydroxychloroquine and colchicine].

C. Aubé, F. Oberti, P. Calès, 1995, Gastroenterologie clinique et biologique.

Impact of type 2 diabetes on the accuracy of non-invasive tests of liver fibrosis with resulting clinical implications.

V. de Lédinghen, B. le Bail, C. Canivet, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

V. de Lédinghen, C. Canivet, T. Decaens, 2022, Hepatology.

[Cholestatic hepatitis caused by carbimazole].

J. Vinel, P. Calès, J. Voigt, 1987, Presse medicale.

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH

S. Bertrais, L. V. Van Gaal, A. Iannelli, 2018, Alimentary pharmacology & therapeutics.

A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis.

V. de Lédinghen, S. Bertrais, R. Anty, 2017, Journal of hepatology.

An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards.

V. de Lédinghen, M. Friedrich-Rust, F. Carrat, 2015, Journal of hepatology.

Reproducibility of blood tests of liver fibrosis in clinical practice.

G. Hunault, F. Oberti, P. Calès, 2008, Clinical biochemistry.

Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification

V. de Lédinghen, B. le Bail, G. Hunault, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.

P. Calès, J. Zarski, N. Sturm, 2013, Clinics and research in hepatology and gastroenterology.

The needs and wishes of outpatients undergoing upper gastrointestinal endoscopy.

P. Calès, P. Burtin, J. Boyer, 1992, Endoscopy.

Effects of positive pressure on both femoral venous and arterial blood velocities and the cutaneous microcirculation of the forefoot.

J L Saumet, P. Abraham, G. Leftheriotis, 1997, Cardiovascular research.

Ultrasonographic elastometry vs. blood tests for the diagnosis of cirrhosis: a Pyrrhic victory?

F. Oberti, P. Calès, J. Boursier, 2009, Journal of hepatology.

Transient elastography vs. blood tests for the diagnosis of cirrhosis: An empiric victory

F. Oberti, P. Calès, J. Boursier, 2009 .

Reproducibility of liver stiffness measurement by ultrasonographic elastometry.

F. Oberti, P. Calès, I. Hubert-Fouchard, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Respective roles of porto‐septal fibrosis and centrilobular fibrosis in alcoholic liver disease

P. Bedossa, D. Chappard, F. Oberti, 2003, The Journal of pathology.

Manifestations extra-hépatiques de l'infection par le virus de l'hépatite A.

F. Oberti, P. Calès, Maïga My, 1996 .

β-blockers and variceal haemorrhage

T. Poynard, P. Calès, D. Lebrec, 1990, The Lancet.

Inter-observer and intra-observer variability in hepatology

C. Aubé, P. Calès, B. Winkfield, 2003, European journal of gastroenterology & hepatology.

Reproducibility in Ultrasonic Characterization of Carotid Plaques

P. Calès, J. de Bray, J. Baud, 1998, Cerebrovascular Diseases.

Assessment of new hyaluronic acid assays and their impact on FibroMeter scores.

F. Oberti, P. Calès, Y. Gallois, 2011, Clinica chimica acta; international journal of clinical chemistry.

Intrafamilial hepatitis E in France.

P. Calès, C. Payan, F. Lunel-Fabiani, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C

P. Marquet, P. Calès, F. Lunel, 2008, Hepatology.

Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy.

V. Rossi, P. Calès, P. Burtin, 1991, Journal of hepatology.

MRI measurement of liver fat content predicts the metabolic syndrome.

S. Bertrais, G. Leftheriotis, R. Andriantsitohaina, 2013, Diabetes & metabolism.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)

V. de Lédinghen, P. Marcellin, S. Chevret, 2015, Hepatology.

[Follow-up of blood donors with positive serology for hepatitis C virus and their recipients is insufficient].

F. Oberti, P. Calès, C. Pilette, 1996, Gastroenterologie clinique et biologique.

Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride–induced cirrhosis

J. Vinel, P. Calès, B. Pipy, 1991, Hepatology.

In vitro and in vivo vascular responses to the L‐type calcium channel activator, Bay K 8644, in rats with cirrhosis

R. Moreau, P. Sogni, F. Oberti, 1998, Journal of gastroenterology and hepatology.

The Leptin to Adiponectin Ratio is a Marker of the Number of Metabolic Syndrome Criteria in French Adults

S. Bertrais, G. Leftheriotis, V. Rohmer, 2012 .

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance

V. de Lédinghen, T. Asselah, D. Thabut, 2021, JHEP Reports.

"Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?"

E. Dajti, G. Marasco, F. Ravaioli, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

524 Liver stiffness measurement (LSM) by transient elastography. predictive factors of accuracy, success and reproducibility

P. Calès, A. Konaté, S. Réaud, 2006 .

Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis

Christophe Aubé, Paul Calès, S. Bertrais, 2010, European journal of gastroenterology & hepatology.

[766] NON INVASIVE TESTS OF LIVER FIBROSIS IN NAFLD

X. Causse, F. Laine, Y. Deugnier, 2007 .

Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests

S. Bertrais, F. Oberti, P. Calès, 2017, Journal of gastroenterology and hepatology.

Clinical interpretation of Fibroscan® results: a real challenge

P. Calès, J. Boursier, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Non‐virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort

P. Marcellin, E. Letouzé, D. Thabut, 2019, Journal of viral hepatitis.

Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!

V. de Lédinghen, G. Hunault, F. Oberti, 2019, Clinical and translational gastroenterology.

Controlled attenuation parameter (CAP): a new device for fast evaluation of liver fat?

P. Calès, J. Boursier, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Hépatotoxicité à la carbamazépine au cours d'un DRESS syndrome

F. Oberti, P. Calès, C. Leclech, 2007 .

Improved fibrosis staging by elastometry and blood test in chronic hepatitis C

G. Hunault, F. Oberti, P. Calès, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Cirrhosis Diagnosis and Liver Fibrosis Staging: Transient Elastometry Versus Cirrhosis Blood Test

V. de Lédinghen, F. Oberti, P. Calès, 2014, Journal of clinical gastroenterology.

Quantification of portal–bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C

P. Calès, M. Rousselet, J. Zarski, 2014, Modern Pathology.

Individual and population screening of varices needing treatment by a simple, safe and accurate test.

V. de Lédinghen, P. Nahon, N. Ganne-Carrié, 2023, Clinics and research in hepatology and gastroenterology.

A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis

S. Bertrais, G. Hunault, F. Oberti, 2018, Hepatology communications.

Editorial: combining elastography with blood test for fibrosis assessment in chronic hepatitis C – authors’ reply

P. Calès, J. Boursier, 2017, Alimentary Pharmacology and Therapeutics.

The prevalence of esophageal varices needing treatment depends on gender, etiology and BMI

P. Nahon, N. Ganne-Carrié, F. Ravaioli, 2020, Journal of Hepatology.

Factors Limiting Complete Tumor Ablation by Radiofrequency Ablation

P. Pereira, C. Aubé, F. Oberti, 2007, CardioVascular and Interventional Radiology.

Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general population

V. Vilgrain, J. Correas, T. Decaens, 2023, Acta radiologica.

697 PRECISE AND SIMPLE QUANTITATION OF LIVER STEATOSIS BY MRI IN AN ANIMAL MODEL AND IN PATIENTS WITH NAFLD

C. Cavaro-Ménard, C. Aubé, P. Calès, 2009 .

Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding

M. Rudler, D. Thabut, J. Golmard, 2015, Hepatology.

[Natural history of esophageal varices in cirrhosis (from origin to rupture)].

P. Calès, J. Pascal, Pascal Jp, 1988, Gastroenterologie clinique et biologique.

[Toxic megacolon caused by loperamide-myorelaxants combination].

P. Calès, A. Bouziane, J. Boyer, 1993, Gastroenterologie clinique et biologique.

Cross‐linkage between bacterial taxonomy and gene functions: a study of metagenome‐assembled genomes of gut microbiota in adult non‐alcoholic fatty liver disease

M. Briand, C. Canivet, O. Bouchez, 2021, Alimentary pharmacology & therapeutics.

Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD

S. Bertrais, C. Cavaro-Ménard, F. Laine, 2011, European journal of gastroenterology & hepatology.

Late recurrence of a hepatic angiomyolipoma.

C. Aubé, F. Oberti, J. Arnaud, 2000, European journal of gastroenterology & hepatology.

Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride–induced cirrhosis

J. Vinel, P. Calès, B. Pipy, 1991, Hepatology.

[Turner syndrome and digestive telangiectasis: an additional value of estrogen-progestational treatment].

F. Oberti, P. Calès, H. Rifflet, 1996, Gastroentérologie Clinique et Biologique.

[The Hepatitis Network in Maine-et-Loire city hospitals: six year follow-up of patients and physicians. Hepatitis Network of Maine-et-Loire].

P. Calès, C. Payan, E. Geagea, 2000, Gastroenterologie clinique et biologique.

[Predictive factors of the first digestive hemorrhage and death in cirrhotic patients with esophageal varices].

P. Calès, 1989, Gastroenterologie clinique et biologique.

Argon plasma coagulation (APC) : An effective endoscopic treatment of bleeding gastric antral vascular ectasia (GAVE)

F. Oberti, P. Calès, É. Vuillemin, 2000 .

Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests

V. de Lédinghen, M. Friedrich-Rust, F. Carrat, 2015, Clinical chemistry and laboratory medicine.

Laser Doppler flowmetry in healthy rats: impact of isoflurane anesthetic on signal complexity

F. Chapeau-Blondeau, P. Asfar, D. Rousseau, 2008, 2008 16th Mediterranean Conference on Control and Automation.

[Acute painful and febrile hepatic involvement related to ingestion of tianeptine].

F. Oberti, P. Calès, C. Pilette, 1996, Gastroenterologie clinique et biologique.

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

V. de Lédinghen, S. Bertrais, F. Oberti, 2017 .

Combination of fibrosis tests: Sequential or synchronous?

P. Calès, J. Boursier, 2009, Hepatology.

Thrombotic thrombocytopenic purpura compli- cating interferon therapy in chronic C hepatitis Purpura thrombotique thrombocytopénique compliquant un traitement par interféron au cours d’une hépatite C chronique Introduction

P. Calès, J. Boursier, A. Sawadogo, 2008 .

Prospective Evidence That Hepatocellular Carcinoma Surveillance in Patients with Compensated Viral Cirrhosis Increases the Probability of Curative Treatment and Survival Taking into Account Lead-Time Bias (Anrs Co12 Cirvir Cohort)

J. Zucman‐Rossi, P. Marcellin, E. Letouzé, 2016 .

Noninvasive liver steatosis quantification using MRI techniques combined with blood markers

C. Cavaro-Ménard, C. Aubé, P. Calès, 2010, European journal of gastroenterology & hepatology.

Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats

D. Chappard, F. Oberti, P. Calès, 2002, Hepatology.

Automated morphometry provides accurate and reproducible virtual staging of liver fibrosis in chronic hepatitis C

S. Bertrais, C. Cavaro-Ménard, G. Hunault, 2015, Journal of Pathology Informatics.

Fibrosis progression under maintenance interferon in hepatitis C is better detected by blood test than liver morphometry

S. Bertrais, C. Michelet, P. Calès, 2012, Journal of viral hepatitis.

Treatment of liver fibrosis: clinical aspects.

F. Oberti, P. Calès, M. Rousselet, 2009, Gastroenterologie clinique et biologique.

Trials in portal hypertension: Valid meta-analyses and valid randomized clinical trials: Portal Hypertension Ii

A. Burroughs, A. Morabito, C. Gluud, 1996 .

Hepatic hyper‐vitaminosis A: importance of retinyl ester level determination

N. Ifrah, F. Oberti, P. Calès, 2000, European journal of gastroenterology & hepatology.

[Circadian rhythms in rat and mouse urinary electrolytes and nitrogen derivatives excretion (author's transl)].

J. Cambar, P. Calès, F. Le Moigne, 1981, Journal de physiologie.

Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding

M. Rudler, D. Thabut, J. Golmard, 2015, Hepatology.

Determination of reliability criteria for liver stiffness evaluation by transient elastography

V. de Lédinghen, S. Bertrais, F. Oberti, 2013, Hepatology.

Acoustic radiation force impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis

F. Oberti, P. Calès, Y. Gallois, 2010, European journal of gastroenterology & hepatology.

Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography

F. Oberti, P. Calès, I. Hubert-Fouchard, 2008, European journal of gastroenterology & hepatology.

The Lack of HER-2/neu Oncogene Amplification in Colorectal Malignancies

S. Yoshida, A. Ohtsu, N. Boku, 2003 .

Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)

V. de Lédinghen, P. Marcellin, S. Chevret, 2015, Hepatology.

Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)

V. de Lédinghen, J. Zucman‐Rossi, D. Thabut, 2023, Quality of Life Research.

Vapreotide acetate for the treatment of esophageal variceal bleeding

P. Calès, 2008, Expert review of gastroenterology & hepatology.

[Cost of hemostatic treatment of hemorrhage due to esophageal varices rupture].

B. Caillaud, F. Oberti, P. Calès, 1998, Gastroentérologie Clinique et Biologique.

[Infection and variceal bleeding in cirrhosis].

P. Asfar, P. Calès, M. Joly-Guillou, 2007, Gastroentérologie Clinique et Biologique.

Fibrosis progression under maintenance interferon in hepatitis C is better detected by blood test than liver morphometry

P. Calès, J. Zarski, G. Babany, 2012, Journal of viral hepatitis.

Reply:

P. Calès, J. Boursier, 2012 .

[Hepatotoxicity of carbamazepine: a case of "DRESS syndrome"].

F. Oberti, P. Calès, C. Leclech, 2007, Gastroenterologie clinique et biologique.

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

S. Bertrais, F. Oberti, P. Calès, 2011, The American Journal of Gastroenterology.

AGILE SCORES IN MASLD AND ALD: EXTERNAL VALIDATION AND THEIR UTILITY IN CLINICAL ALGORITHMS.

V. de Lédinghen, M. Thiele, O. Elshaarawy, 2024, Journal of Hepatology.

Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements

L. Ridola, P. Calès, J. Boursier, 2023, Hepatology.

Obstructive sleep apnoea severity and liver steatosis measured by magnetic resonance imaging

P. Abraham, R. Andriantsitohaina, C. Aubé, 2019, European Respiratory Journal.

246 ASSESSMENT OF PAROXETINE IN THE PREVENTION OF DEPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C TREATED BY PEG-INTERFERON-RIBAVIRIN.: A DOUBLE-BLINDED, RANDOMIZED STUDY. ANRS HC18 PAROPEG

S. Pol, A. Tran, J. Molina, 2010 .